NCT05445167 2025-11-25
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
Clinical Trials
83 trialsNCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT06949124 2025-09-10
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
NCT02748460 2025-09-02
Premium
PregLem SA
Completed
NCT06969664 2025-08-19
A Trial of SHR7280 in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT05440383 2025-03-14
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT05868057 2023-12-08
A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT05986266 2023-10-17
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss
Egymedicalpedia
Phase 1 Completed
NCT05086770 2023-07-14
Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
Next Biomedical Co., Ltd.
Phase NA Completed
NCT01563783 2023-02-01
TRUST
Acessa Health, Inc.
Phase NA Completed
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03886220 2022-03-31
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 4 Completed
NCT00731341 2021-07-19
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
Boston Scientific Corporation
Phase NA Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT02925494 2021-07-13
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
AbbVie
Phase 3 Completed
NCT03070899 2021-06-09
PRIMROSE 1
ObsEva SA
Phase 3 Completed
NCT03070951 2021-03-05
PRIMROSE 2
ObsEva SA
Phase 3 Completed
NCT03744507 2020-11-10
Bone Mineral Density in Women With Uterine Fibroids or Endometriosis
Myovant Sciences GmbH
Completed
NCT01817530 2020-07-21
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie
Phase 2 Completed
NCT02654054 2020-06-29
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02580578 2020-02-28
A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
Allergan
Completed
NCT02228174 2020-02-11
SONATA
Gynesonics
Phase NA Completed
NCT03411980 2019-12-03
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
Bayer
Phase 1 Completed
NCT02844920 2019-09-20
OPEN
Gynesonics
Completed
NCT03427671 2019-09-12
OCL 500 Treatment of Women With Symptomatic Uterine Fibroids
IMBiotechnologies Ltd.
Phase NA Completed
NCT01629563 2019-09-04
PEARLIV
PregLem SA
Phase 3 Completed
NCT02889848 2019-07-10
Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)
Advance Biofactures Corporation
Phase 1 Completed
NCT02323646 2019-06-25
Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Completed
NCT02301897 2019-06-19
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Completed
NCT00958334 2019-06-18
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
Repros Therapeutics Inc.
Phase 2 Completed
NCT00131365 2019-06-12
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids
InSightec
Phase NA Completed
NCT02147197 2019-04-30
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Allergan
Phase 3 Completed
NCT02655224 2019-03-22
A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids
Takeda
Phase 3 Completed
NCT01142791 2019-03-19
Safety Study of ExAblate for the Treatment of Uterine Fibroids
InSightec
Phase NA Completed
NCT01285960 2019-03-06
ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids
InSightec
Phase NA Completed
NCT00365989 2019-02-05
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
InSightec
Phase 3 Completed
NCT00295217 2018-12-20
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
InSightec
Phase 3 Completed
NCT01750008 2018-11-20
LUSTOR
Acessa Health, Inc.
Phase NA Completed
NCT00166270 2018-07-09
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
InSightec
Phase NA Completed
NCT02131662 2017-12-08
ASTEROID 1
Bayer
Phase 2 Completed
NCT01152112 2017-09-13
HOME
Hologic, Inc.
Phase NA Completed
NCT01369758 2017-09-13
MyoSure Hysteroscopic Tissue Removal System Registry Study
Hologic, Inc.
Phase NA Completed
NCT00891657 2017-09-07
Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy
Integra LifeSciences Corporation
Phase NA Completed
NCT02835391 2017-09-01
PerClot Compared to Usual Care in Gynaecology Procedures
CryoLife Europa
Phase NA Completed
NCT03092999 2017-08-18
Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)
Bayer
Phase 1 Completed
NCT01946178 2017-05-30
Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids
Mirabilis Medica, Inc.
Phase NA Completed
NCT02465814 2016-11-22
ASTEROID 2
Bayer
Phase 2 Completed